About Index Trending news
Lists
Pricing
Seattle Genetics

Seattle Genetics

Seattle Genetics

Biotechnology company focused on innovative monoclonal antibody-based therapies for the treatment of cancer. View our Twitter guidelines our site

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$9,000,000
Employees

Unknown size

GeekWire

Seattle Genetics beats earnings expectations as lead drug Adcetris finds market success

Earnings Health
GeekWire , Xconomy

Seattle Genetics cancer drug clinical trials will go forward after FDA lifts hold

Health
Xconomy

Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights

Health
GeekWire

Shares of Seattle Genetics tumble after FDA places clinical hold on leukemia drug following patient deaths

GeekWire

Seattle Genetics announces successful clinical trial of lymphoma treatment

Health Science
The Motley Fool

Seattle Genetics Has Been Heating Up: Time to Buy?

The Motley Fool

Taking Inventory on Seattle Genetics, Inc. Earnings

Earnings Health Stock markets
The Motley Fool

Why Seattle Genetics, Inc. Stock Rose 10% in March

The Motley Fool

Seattle Genetics, Inc. Grows Sales, Waits for Data

Health Earnings
GeekWire

Despite record sales of cancer drug, Seattle Genetics shares fall 7 percent

Earnings Health